<DOC>
	<DOCNO>NCT00364091</DOCNO>
	<brief_summary>The purpose summary evaluate efficacy safety R89674 0.025 % ophthalmic solution compare placebo active control subject seasonal allergic conjunctivitis</brief_summary>
	<brief_title>Evaluation Efficacy Ophthalmic Solution Seasonal Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis , Allergic</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>history positive diagnostic test ragweed within past 2 year ; positive bilateral response ragweed induce conjunctival allergen challenge ocular infection ; history retinal detachment , diabetic neuropathy , progressive retinal disease ; moderate severe asthma ; dry eye syndrome ; history severe , unstable , uncontrolled cardiovascular , pulmonary , hepatic , renal autoimmune disease ; pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>allergic conjunctivitis , ophthalmology , multicenter , control</keyword>
</DOC>